1. Home
  2. MLGO vs EDSA Comparison

MLGO vs EDSA Comparison

Compare MLGO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroAlgo Inc.

MLGO

MicroAlgo Inc.

HOLD

Current Price

$4.10

Market Cap

49.9M

Sector

Technology

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$5.41

Market Cap

51.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLGO
EDSA
Founded
2018
2015
Country
China
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
51.6M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MLGO
EDSA
Price
$4.10
$5.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
29.1K
51.2K
Earning Date
04-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$87,132,230.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.91
N/A
Revenue Growth
6.21
N/A
52 Week Low
$3.02
$0.72
52 Week High
$13.60
$20.32

Technical Indicators

Market Signals
Indicator
MLGO
EDSA
Relative Strength Index (RSI) 46.69 43.28
Support Level $3.95 $4.80
Resistance Level $4.44 $5.82
Average True Range (ATR) 0.17 0.54
MACD 0.02 0.09
Stochastic Oscillator 28.40 68.32

Price Performance

Historical Comparison
MLGO
EDSA

About MLGO MicroAlgo Inc.

MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: